Anaerobic infections.
D000900:Anti-Bacterial Agents / Q000494:pharmacology / Q000627:therapeutic use*; D001421:Bacteria, Anaerobic / Q000187:drug effects; D001424:Bacterial Infections / Q000175:diagnosis / Q000188:drug therapy*; D002440:Cefoxitin / Q000494:pharmacology / Q000627:therapeutic use; D002648:Child; D002675:Child, Preschool; D002701:Chloramphenicol / Q000494:pharmacology / Q000627:therapeutic use; D002981:Clindamycin / Q000494:pharmacology / Q000627:therapeutic use; D006801:Humans; D007223:Infant; D007231:Infant, Newborn; D010400:Penicillin G / Q000494:pharmacology / Q000627:therapeutic use; D010403:Penicillin Resistance
D000900:Anti-Bacterial Agents; D002981:Clindamycin; D002701:Chloramphenicol; D002440:Cefoxitin; D010400:Penicillin G